Cefadroxil is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for viral infections. Technically, cefadroxil is an orally active first generation cephalosporin that inhibits bacterial cell wall synthesis through high affinity binding to penicillin binding proteins resulting in bactericidal activity. It has good oral absorption, substantial renal excretion of unchanged drug, and a serum half life that supports once or twice daily dosing depending on infection severity and renal function. Clinical use targets gram positive organisms including streptococci and many staphylococci and selected gram negative enteric bacilli. Important considerations include dose adjustment in renal impairment, avoidance in patients with known severe immediate hypersensitivity to beta lactams unless allergy evaluation permits use, and monitoring for gastrointestinal adverse effects and Clostridioides difficile associated diarrhea during therapy.

Parent: Amoxicillin/ Cefadroxil/ Cefprozil
Parent: Cefadroxil
Parent: Cefadroxil / Cefadroxil Monohydrate
Parent: Cefadroxil
Parent: Cefadroxil
Parent: Cefalexin/ Cefadroxil
Parent: Cefadroxil
Parent: Cefadroxil
Active substance and finished product specifications for cefadroxil typically follow pharmacopeial related-substance testing and set fixed quantitative limits for both specified and unspecified impurities. Typical control ranges used by manufacturers and regulators are individual specified related compounds generally limited to 0.2 to 1.0 percent by area or weight depending on impurity identity, unspecified impurities commonly limited to 0.1 to 0.5 percent each, and a total impurities limit commonly in the range of 2.0 to 3.0 percent. Common related compounds monitored by stability and quality control methods include deacylated degradation products, epimeric isomers at the 7 position, desamination or oxidation products and other low molecular weight degradants; specified impurity limits are set based on toxicity, route of formation and stability data. Residual solvents and heavy metals are controlled to applicable pharmacopeial levels and exact acceptance criteria are defined in the manufacturer specification and relevant pharmacopoeial monograph.
Cefadroxil is used to treat susceptible bacterial infections such as uncomplicated skin and soft tissue infections, pharyngitis and tonsillitis caused by streptococci, and selected urinary tract infections; therapy selection should be guided by local susceptibility data and clinical judgment.
Small amounts of cefadroxil are excreted in breast milk; it is generally considered compatible with breastfeeding but mothers should consult a prescriber because individual clinical circumstances, neonatal prematurity and infant renal function may influence risk and monitoring.
Cefadroxil is a first generation cephalosporin.
Cefadroxil is not a penicillin; it is a beta lactam antibiotic in the cephalosporin family and shares the beta lactam ring with penicillins, so cross-reactivity can occur in some patients with immediate hypersensitivity to penicillins and use should follow allergy assessment.